Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
716.75
Change Change %
-5.85 -0.81%

Updated:18 Feb, 2019, 15:57 PM IST

BSE
718.05
Change Change %
-4.80 -0.66%

Updated:18 Feb, 2019, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Credit Suisse
N/A
03-05-2016 Buy 792.20 950.00
N/A
Closed Long (1Y)
03-05-2017

Credit Suisse maintains outperform on Aurobindo Pharma

Company will be a beneficiary of faster approvals in US. Margin expansion will be driven by improving product mix. Expect 38 per cent profit growth over next 2 quarters. Expect operating profit CAGR of 22 per cent over FY2016-18. Auro Pharma is favourably placed on growth and return against its peers.

Top